IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i20p10611-d653109.html
   My bibliography  Save this article

Integration of Consumer-Based Activity Monitors into Clinical Practice for Children with Type 1 Diabetes: A Feasibility Study

Author

Listed:
  • Jason R. Jaggers

    (Wendy Novak Diabetes Center, Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, Norton Children’s Hospital, Louisville, KY 40202, USA
    Department of Health and Sport Sciences, University of Louisville, Louisville, KY 40292, USA)

  • Timothy McKay

    (Wendy Novak Diabetes Center, Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, Norton Children’s Hospital, Louisville, KY 40202, USA)

  • Kristi M. King

    (Wendy Novak Diabetes Center, Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, Norton Children’s Hospital, Louisville, KY 40202, USA
    Department of Health and Sport Sciences, University of Louisville, Louisville, KY 40292, USA)

  • Bradly J. Thrasher

    (Wendy Novak Diabetes Center, Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, Norton Children’s Hospital, Louisville, KY 40202, USA)

  • Kupper A. Wintergerst

    (Wendy Novak Diabetes Center, Department of Pediatrics, Division of Endocrinology, School of Medicine, University of Louisville, Norton Children’s Hospital, Louisville, KY 40202, USA)

Abstract

Current technology commonly utilized in diabetes care includes continuous glucose monitors (CGMs) and insulin pumps. One often overlooked critical component to the human glucose response is daily physical activity habits. Consumer-based activity monitors may be a valid way for clinics to collect physical activity data, but whether or not children with type 1 diabetes (T1D) would wear them or use the associated mobile application is unknown. Therefore, the purpose of this study was to test the feasibility of implementing a consumer-based accelerometer directly into ongoing care for adolescents managing T1D. Methods: Adolescents with T1D were invited to participate in this study and instructed to wear a mobile physical activity monitor while also completing a diet log for a minimum of 3 days. Clinical compliance was defined as the number of participants who were compliant with all measures while also having adequate glucose recordings using either a CGM, insulin pump, or on the diet log. Feasibility was defined as >50% of the total sample reaching clinical compliance. Results: A total of 57 children and teenagers between the ages of 7 and 19 agreed to participate in this study and were included in the final analysis. Chi-square results indicated significant compliance for activity tracking ( p < 0.001), diet logs ( p = 0.04), and overall clinical compliance ( p = 0.04). Conclusion: More than half the children in this study were compliant for both activity monitoring and diet logs. This indicates that it is feasible for children with T1D to wear a consumer-based activity monitor while also recording their diet for a minimum of three days.

Suggested Citation

  • Jason R. Jaggers & Timothy McKay & Kristi M. King & Bradly J. Thrasher & Kupper A. Wintergerst, 2021. "Integration of Consumer-Based Activity Monitors into Clinical Practice for Children with Type 1 Diabetes: A Feasibility Study," IJERPH, MDPI, vol. 18(20), pages 1-9, October.
  • Handle: RePEc:gam:jijerp:v:18:y:2021:i:20:p:10611-:d:653109
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/20/10611/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/18/20/10611/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kristi M. King & Timothy McKay & Bradly J. Thrasher & Kupper A. Wintergerst, 2022. "Maximal Oxygen Uptake, VO 2 Max, Testing Effect on Blood Glucose Level in Adolescents with Type 1 Diabetes Mellitus," IJERPH, MDPI, vol. 19(9), pages 1-7, May.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:20:p:10611-:d:653109. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.